Ropes & Gray represented the underwriters in Biohaven Ltd.’s $264.5 million follow-on offering. Biohaven intends to use the proceeds from the offering to fund general corporate purposes. The offering was announced in a press release on April 18 and closed on April 22.

Biohaven is a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience and oncology.

The team was led by capital markets partners Will Michener and Daniel Forman, IP transactions partner Melissa Rones, life sciences regulatory & compliance partner Kellie Combs, and tax partner David Saltzman.